John Paul Johnson's most recent trade in Evolent Health Inc - Ordinary Shares - Class A was a trade of 25,461 Class A Common Stock done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 25,461 | 309,245 (0%) | 0% | 0 | Class A Common Stock | |
| Johnson & Johnson | Paula A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 1,316 | 4,265 | - | - | Deferred Share Units | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 89,113 | 251,074 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 59,582 | 310,656 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.77 per share. | 01 Mar 2025 | 26,872 | 283,784 (0%) | 0% | 8.8 | 235,667 | Class A Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.99 per share. | 01 Mar 2025 | 9,246 | 161,961 (0%) | 0% | 9.0 | 83,122 | Class A Common Stock |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 18,480 | 18,480 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 6,826 | 64,573 (0%) | 0% | 0 | Common Stock | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 57,581 | 57,581 (0%) | 0% | 0 | Common Stock | |
| Corteva | David Paul Johnson | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 23,606 | 23,606 | - | - | Non-Qualified Stock Option (right to buy) | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Aug 2024 | 44,693 | 171,207 (0%) | 0% | 30 | 1,340,790 | Class A Common Stock |
| Lifecore Biomedical Inc | Paul H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 24,554 | 24,554 (0%) | 0% | - | Common Stock | |
| Johnson & Johnson | Paula A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 1,385 | 2,858 | - | - | Deferred Share Units | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 16 | 32,502 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 15 | 32,486 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Sale of securities on an exchange or to another person at price $ 172.84 per share. | 04 Mar 2024 | 12,701 | 32,471 (0%) | 0% | 172.8 | 2,195,228 | Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,123 | 236,133 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.41 per share. | 01 Mar 2024 | 11,213 | 224,920 (0%) | 0% | 34.4 | 385,839 | Class A Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.41 per share. | 01 Mar 2024 | 9,020 | 215,900 (0%) | 0% | 34.4 | 310,378 | Class A Common Stock |
| Evolent Health Inc - Ordin... | Johnson John Paul | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 44,000 | 244,016 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | Paul Johnson John | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.03 per share. | 22 Feb 2024 | 20,006 | 224,010 (0%) | 0% | 33.0 | 660,798 | Class A Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 20,905 | 54,041 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.41 per share. | 17 Nov 2023 | 8,869 | 45,172 (0%) | 0% | 131.4 | 1,165,475 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.41 per share. | 17 Nov 2023 | 890 | 33,136 (0%) | 0% | 131.4 | 116,955 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.23 per share. | 16 Nov 2023 | 367 | 34,026 (0%) | 0% | 135.2 | 49,629 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2023 | 4,749 | 34,393 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.29 per share. | 11 Nov 2023 | 470 | 29,644 (0%) | 0% | 132.3 | 62,176 | Common Stock |
| MedAvail Holdings Inc | Paul D. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 545,455 | 545,455 | - | - | Stock Options (Right to Buy) | |
| Johnson & Johnson | Paula A. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 1,429 | 1,429 | - | - | Deferred Share Units | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 1,828 | 3,655 | - | - | Restricted Stock Units | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 1,828 | 2,675 (0%) | 0% | 0 | Common Stock | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 1,172 | 3,227 (0%) | 0% | 0 | Common Stock | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 1,172 | 1,172 | - | - | Restricted Stock Units | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.87 per share. | 15 Mar 2023 | 620 | 2,055 (0%) | 0% | 19.9 | 12,319 | Common Stock |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.97 per share. | 15 Mar 2023 | 398 | 2,829 (0%) | 0% | 20.0 | 7,948 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Sale of securities on an exchange or to another person at price $ 149.79 per share. | 09 Mar 2023 | 10,000 | 30,114 (0%) | 0% | 149.8 | 1,497,877 | Common Stock |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 7,706 | 7,706 | - | - | Performance Stock Units | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 5,138 | 5,138 | - | - | Restricted Stock Units | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 20,413 | 212,717 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.15 per share. | 01 Mar 2023 | 9,020 | 200,016 (0%) | 0% | 35.2 | 317,053 | Class A Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.26 per share. | 01 Mar 2023 | 3,681 | 209,036 (0%) | 0% | 35.3 | 129,792 | Class A Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 44,000 | 212,329 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.08 per share. | 21 Feb 2023 | 20,025 | 192,304 (0%) | 0% | 28.1 | 562,302 | Class A Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 14,239 | 46,420 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.15 per share. | 21 Nov 2022 | 6,306 | 40,114 (0%) | 0% | 117.2 | 738,748 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.15 per share. | 21 Nov 2022 | 645 | 32,181 (0%) | 0% | 117.2 | 75,562 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.62 per share. | 17 Nov 2022 | 929 | 32,826 (0%) | 0% | 100.6 | 93,476 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2022 | 6,243 | 6,243 | - | - | Stock Options (right to buy) | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2022 | 3,320 | 34,139 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.61 per share. | 11 Nov 2022 | 384 | 33,755 (0%) | 0% | 104.6 | 40,170 | Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 34.11 per share. | 17 Aug 2022 | 18,434 | 168,329 (0%) | 0% | 34.1 | 628,784 | Class A Common Stock |
| MedAvail Holdings Inc | Paul D. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 116,505 | 116,505 | - | - | Common Stock | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 1,172 | 1,172 (0%) | 0% | 0 | Common Stock | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 1,172 | 2,344 | - | - | Restricted Stock Units | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.12 per share. | 16 Mar 2022 | 325 | 847 (0%) | 0% | 19.1 | 6,214 | Common Stock |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 8,224 | 8,224 | - | - | Performance Stock Units | |
| Myers Industries Inc. | Paul Allan Johnson | VP, Distribution Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 5,483 | 5,483 | - | - | Restricted Stock Units | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 71,716 | 0 | - | - | Leveraged Restricted Stock Unit | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 71,716 | 228,127 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.54 per share. | 02 Mar 2022 | 32,344 | 186,763 (0%) | 0% | 27.5 | 890,754 | Class A Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.54 per share. | 02 Mar 2022 | 9,020 | 219,107 (0%) | 0% | 27.5 | 248,411 | Class A Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 24,000 | 160,921 (0%) | 0% | 0 | Class A Common Stock | |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.40 per share. | 01 Mar 2022 | 4,510 | 156,411 (0%) | 0% | 27.4 | 123,574 | Class A Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Sale of securities on an exchange or to another person at price $ 118.35 per share. | 10 Feb 2022 | 15,500 | 30,819 (0%) | 0% | 118.3 | 1,834,388 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2021 | 27,502 | 58,503 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.82 per share. | 27 Nov 2021 | 12,184 | 46,319 (0%) | 0% | 105.8 | 1,289,311 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.82 per share. | 27 Nov 2021 | 1,032 | 31,001 (0%) | 0% | 105.8 | 109,206 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.65 per share. | 21 Nov 2021 | 645 | 32,033 (0%) | 0% | 111.6 | 72,014 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 5,508 | 5,508 | - | - | Stock Options (right to buy) | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 2,596 | 33,607 (0%) | 0% | 0 | Common Stock | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.00 per share. | 16 Nov 2021 | 929 | 32,678 (0%) | 0% | 103 | 95,687 | Common Stock |
| 23andMe Holding Co - Ordin... | Paul D. Johnson | VP, General Manager-Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 414,886 | 414,886 | - | - | Stock Option (Right to Buy) | |
| Choiceone Financial Servic... | Paul L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 24.75 per share. | 01 Oct 2021 | 101 | 53,393 (0%) | 0% | 24.8 | 2,500 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.87 per share. | 01 Sep 2021 | 2,266 | 31,011 (0%) | 0% | 90.9 | 205,911 | Common Stock |
| Choiceone Financial Servic... | Paul L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 24.22 per share. | 01 Jul 2021 | 103 | 53,292 (0%) | 0% | 24.2 | 2,495 | Common Stock |
| Choiceone Financial Servic... | Paul L. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 24.05 per share. | 27 Apr 2021 | 1,000 | 53,189 (0%) | 0% | 24.1 | 24,050 | Common Stock |
| Choiceone Financial Servic... | Paul L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 24.05 per share. | 01 Apr 2021 | 104 | 52,189 (0%) | 0% | 24.0 | 2,501 | Common Stock |
| Evolent Health Inc - Ordin... | John Paul Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 40,000 | 136,921 (0%) | 0% | 0 | Class A Common Stock | |
| Choiceone Financial Servic... | Paul L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 30.81 per share. | 01 Jan 2021 | 162 | 51,989 (0%) | 0% | 30.8 | 4,991 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.87 per share. | 27 Nov 2020 | 1,032 | 33,277 (0%) | 0% | 39.9 | 41,146 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.00 per share. | 21 Nov 2020 | 645 | 34,309 (0%) | 0% | 34 | 21,930 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2020 | 13,930 | 13,930 | - | - | Stock Options (right to buy) | |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2020 | 6,292 | 34,954 (0%) | 0% | 0 | Common Stock | |
| Choiceone Financial Servic... | Paul L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 26.02 per share. | 01 Oct 2020 | 96 | 51,827 (0%) | 0% | 26.0 | 2,498 | Common Stock |
| Atkore Inc | David Paul Johnson | Vice President and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.65 per share. | 01 Sep 2020 | 2,266 | 28,662 (0%) | 0% | 27.7 | 62,655 | Common Stock |